凱中精密(002823.SZ):實控人擬以大宗交易向豐田通商定向轉讓不超80萬股
格隆匯 10 月 22日丨凱中精密(002823.SZ)公佈,公司與豐田通商(中國)有限公司(“豐田通商”)於2020年10月22日簽署《戰略合作框架協議》。豐田通商認可公司內在價值和看好未來發展,為加強雙方戰略合作伙伴關係,進一步推進公司新能源汽車“三電”發展戰略,公司實際控制人張浩宇擬自公告披露之日起3個交易日後至2020年10月31日前,以大宗交易方式向豐田通商定向轉讓公司股份不超過80萬股,不超過公司總股本比例0.28%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.